Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Makenzie T. Lewis"'
Autor:
Daniel S. Barth, Kirk W. Johnson, Lisa I. Greene, Peter M. Grace, Hang Yin, Linda R. Watkins, Mark R. Hutchinson, Xiaohui Wang, Keith A. Strand, Khara M. Ramos, Kelly N. Morgan, Yingning Zhang, Juliet L. Kroll, Debra Berkelhammer, Thomas A. Cochran, Kenner C. Rice, Krista M. Rodgers, Madeline G. Huey, Steven F. Maier, Frederick R. Taylor, Makenzie T. Lewis
Publikováno v:
Neuroscience. 280:299-317
CNS immune signaling contributes to deleterious opioid effects including hyperalgesia, tolerance, reward, and dependence/withdrawal. Such effects are mediated by opioid signaling at toll-like receptor 4 (TLR4), presumptively of glial origin. Whether
Autor:
Mark R. Hutchinson, Paige W. Sholar, Khara M. Ramos, Makenzie T. Lewis, Kenner C. Rice, Nicole Y. Crysdale, Julie Wieseler, Yingning Zhang, Steven F. Maier, Lisa C. Loram, Linda R. Watkins, Jacqueline A. Harrison, Jeffrey J. Kearney
Publikováno v:
Neuroscience. 164:1821-1832
Spinal cord microglial toll-like receptor 4 (TLR4) has been implicated in enhancing neuropathic pain and opposing morphine analgesia. The present study was initiated to explore TLR4-mediated pain modulation by intrathecal lipopolysaccharide, a classi
Autor:
Khara M. Ramos, Evan M. Sloane, Jacqueline A. Harrison, Juliet L. Kroll, Makenzie T. Lewis, Linda R. Watkins, Steven F. Maier, Frederick R. Taylor, Kelly N. Morgan, Nicole Y. Crysdale
Publikováno v:
Neuroscience. 169(4)
Glutamate neurotransmission is highly regulated, largely by glutamate transporters. In the spinal cord, the glutamate transporter GLT-1 is primarily responsible for glutamate clearance. Downregulation of GLT-1 can occur in activated astrocytes, and i
Autor:
Evan M. Sloane, Erin D. Milligan, Luke D. Amer, Linda R. Watkins, Scott M. Johnson, Stephen Poole, Makenzie T. Lewis, Jacqueline A. Harrison, Ellen C. Dengler, Courtney S. Young, Melissa J. Mahoney, Lisa C. Loram, Ryan G. Soderquist, Matthew G. Frank
Publikováno v:
Pharmaceutical research. 27(5)
Interleukin-10 (IL-10) is an anti-inflammatory molecule that has achieved interest as a therapeutic for neuropathic pain. In this work, the potential of plasmid DNA-encoding IL-10 (pDNA-IL-10) slowly released from biodegradable microparticles to prov